Pryme NV
OSE:PRYME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pryme NV
OSE:PRYME
|
NL |
|
InnoCare Pharma Ltd
SSE:688428
|
CN |
|
Cashlez Worldwide Indonesia Tbk PT
IDX:CASH
|
ID |
|
Reinsurance Group of America Inc
NYSE:RGA
|
US |
|
Haynes International Inc
NASDAQ:HAYN
|
US |
|
S
|
SDIC Zhonglu Fruit Juice Co Ltd
SSE:600962
|
CN |
|
Sparebanken Vest
OSE:SVEG
|
NO |
|
Henan Yuguang Gold & Lead Co Ltd
SSE:600531
|
CN |
|
S
|
Say Yenilenebilir Enerji Ekipmanlari Sanayi ve Ticaret AS
IST:SAYAS.E
|
TR |
|
MTG Co Ltd
TSE:7806
|
JP |
|
E
|
Elite Semiconductor Microelectronics Technology Inc
TWSE:3006
|
TW |
|
Palayan Resources Inc
OTC:PLYN
|
PH |
|
ITFor Inc
TSE:4743
|
JP |
|
I
|
Intertainment AG
XETRA:ITN
|
DE |
|
Vipul Ltd
NSE:VIPULLTD
|
IN |
|
China Resources Power Holdings Co Ltd
HKEX:836
|
HK |
|
F
|
Fibra Mty SAPI de CV
BMV:FMTY14
|
MX |
|
Target Corp
NYSE:TGT
|
US |
|
Sapphire Foods India Ltd
NSE:SAPPHIRE
|
IN |
|
Avanos Medical Inc
NYSE:AVNS
|
US |
Balance Sheet
Balance Sheet Decomposition
Pryme NV
Pryme NV
Balance Sheet
Pryme NV
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1
|
0
|
8
|
12
|
8
|
6
|
7
|
|
| Cash Equivalents |
1
|
0
|
8
|
12
|
8
|
6
|
7
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
1
|
1
|
3
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Total Current Assets |
2
|
1
|
10
|
13
|
10
|
10
|
13
|
|
| PP&E Net |
8
|
9
|
20
|
42
|
46
|
14
|
12
|
|
| PP&E Gross |
0
|
0
|
0
|
42
|
46
|
14
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
7
|
34
|
0
|
|
| Intangible Assets |
2
|
2
|
3
|
6
|
6
|
5
|
4
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
2
|
0
|
0
|
|
| Total Assets |
13
N/A
|
12
-3%
|
32
+165%
|
62
+93%
|
62
-1%
|
29
-52%
|
29
-1%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
2
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
4
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
4
|
0
|
3
|
4
|
|
| Total Current Liabilities |
1
|
1
|
1
|
6
|
7
|
7
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
11
|
12
|
14
|
13
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Liabilities |
5
|
5
|
5
|
5
|
3
|
2
|
1
|
|
| Total Liabilities |
6
N/A
|
6
+3%
|
6
-3%
|
23
+310%
|
22
-2%
|
23
+3%
|
20
-14%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
2
|
2
|
3
|
0
|
|
| Retained Earnings |
0
|
1
|
3
|
8
|
23
|
68
|
0
|
|
| Additional Paid In Capital |
0
|
7
|
30
|
46
|
60
|
71
|
0
|
|
| Other Equity |
7
|
0
|
0
|
0
|
0
|
0
|
9
|
|
| Total Equity |
7
N/A
|
6
-8%
|
27
+314%
|
40
+49%
|
39
-1%
|
7
-83%
|
9
+43%
|
|
| Total Liabilities & Equity |
13
N/A
|
12
-3%
|
32
+165%
|
62
+93%
|
62
-1%
|
29
-52%
|
29
-1%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
3
|
5
|
6
|
32
|
|